This document summarizes the use of sentinel lymph node biopsy (SLNB) in gynecological malignancies, specifically vulvar cancer. It discusses how SLNB can help stage and predict prognosis in vulvar cancer patients, with a lower morbidity than traditional inguinal lymphadenectomy. Several studies demonstrated high detection rates of over 95% and low false negative rates of less than 10% when using radiotracer and blue dye to map sentinel lymph nodes in vulvar cancer patients. Larger multicenter trials provide further support for the accuracy and reduced complications of SLNB compared to lymphadenectomy in early stage vulvar cancer.
Endometrial hyperplasia - irregular proliferation of the endometrial glands with an increase in the gland to stroma ratio when compared with proliferative endometrium
Endometrial Ca - most common gynaecological maglinancy in the western country, endometrial hyperplasia as the precursor
Incidence of endometrial hyperplasia 3 folds higher than endometrial Ca
Fourth most common cancer in women in Peninsular Malaysia
Presentation at Chittaranjan Seva Sadan, Kolkata where Dr Dasgupta was invited as faculty in the CME organized by Medical Education and research Committee, Bengal Obstetrics and Gynaecological Society
Surrogacy Regulation Act 2021 has been notified in the Gazette on 25th December 2021 and there are important implications for all who practice surrogacy in India both for patients and clinics and ART Banks.
Endometrial hyperplasia - irregular proliferation of the endometrial glands with an increase in the gland to stroma ratio when compared with proliferative endometrium
Endometrial Ca - most common gynaecological maglinancy in the western country, endometrial hyperplasia as the precursor
Incidence of endometrial hyperplasia 3 folds higher than endometrial Ca
Fourth most common cancer in women in Peninsular Malaysia
Presentation at Chittaranjan Seva Sadan, Kolkata where Dr Dasgupta was invited as faculty in the CME organized by Medical Education and research Committee, Bengal Obstetrics and Gynaecological Society
Surrogacy Regulation Act 2021 has been notified in the Gazette on 25th December 2021 and there are important implications for all who practice surrogacy in India both for patients and clinics and ART Banks.
Presentation from Southern California Chapter of the American College of Surgeons 2014 - "Extranodal Extension on Sentinel Lymph Node Dissection: Why Should We Treat It Differently?"
This data has since been published in The American Surgeon.
http://www.ncbi.nlm.nih.gov/pubmed/25264632
These slides are from versions of a talk I gave at ESTRO in 2014 and again in Lille in 2015.
The talk aims to explain the importance of correctly defining the CTV with respect to nodes in curative radiotherapy planning.
The lecture makes some important points about the function of lymph glands and their potential to act as stem cell 'rests' for malignant cells: this fact might explain whilst lymph node failure rates don't necessarily equate to disease failure rates.
The lecture then goes on to emphasise the utility of the best imaging technologies may more accurately identify involved nodes.
Shrinking fields with confidence may be the best way to reduce radiation toxicity.
Dr Ian Katz, Dermatopathologist, from Southern Sun Skin Cancer Clinic and Southern Sun Pathology, discusses the pro and cons of using shave biopsies in clinical skin cancer practice.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
1. Sen$nel
Lymph
node
in
Gynecological
malignancies
Khalid
Sait
FRCSC
Professor,
Faculty
of
medicine,
King
Abdulaziz
University
Jeddah,
Saudi
Arabia
2. Sen$nel
lymph
node
(SLN)
• SLN:
The
first
lymph
node
in
a
chain
of
lymph
nodes
within
a
lympha$c
basin
that
receives
drainage
from
the
primary
tumor.
3.
If
SLN
is
nega$ve,
the
remainder
of
the
lymph
nodes
in
the
nodal
basin
should
be
free
of
disease
as
well
4.
5.
6. Advantage
of
SLNS
• Decrease
short-‐term
and
long-‐term
morbidity
associated
with
complete
nodal
dissec$ons
• Reduced
opera$ve
$me.
• Reduced
blood
loss.
• Reduc$on
in
nerve,
blood
vessel,
and
ureteral
injuries.
• Increased
iden$fica$on
of
metasta$c
lymph
nodes
through
ultra-‐staging
.
• It
may
iden$fy
lymph
nodes
in
areas
that
may
not
be
dissected
in
a
standard
lymphadenectomy
9. Vulva
Cancer
• Vulva
:-‐
– Superficial
inguinal
lymph
nodes,
.
– Deep
inguinal
Lymph
nodes.
– Femoral
lymph
nodes..
– Deep
pelvic
nodes
including;
the
external
iliac,
common
iliac,
then
para-‐aor$c
lymph
nodes.
10. Current
standard
radical
wide
local
excision
and
either
deep
or
superfacial
inguinal
node
dissec$on
radical
vulvectomy
with
en
bloc
inguinal
femoral
lymphadnectomy
wound
breakdown
chronic
lymphedema
85%
30-‐70
%
70%
20-‐40
%
Morbidity
Historical
Standard
Treatment
of
Early
stage
Vulvar
Cancer
12. Staging
• Only
27
%
of
pa$ents
who
undergo
inguinal
lymphadnectomy
will
have
posi$ve
node
• i.e
more
than
70
%
of
women
will
have
an
inguinal
node
dissec$on
with
out
any
clinical
benefit.
13. Prognosis
• 5
years
survival
rate
in
pa$ents
with:
v
nega$ve
inguinal
lymph.
node
is
96%
v
Less
or
two
posi$ve
is
80
%
v
More
than
two
is
12
%
16. Technique
for
sen$nel
node
• Blue
Dye
:-‐
– Injected
into
the
$ssue
surrounding
the
tumour
.
• Radiolymphoscin5graphy
:-‐
– Radio
ac$ve
tracers
usually
Techne$um-‐99m:
• Techne$um
with
sulfur
colloid
injected
2-‐4
pre
OP.
• Techne$um
with
albumin
injected
pre-‐op
day
1.
18. Authors No. of Patients Detection method Detection percentage Faise-negative percentage
Levenback (1995) 21 blue day 66 0
DeCesare (1997) 10 blue day + radiocolloid 100 0
Ansink (1999) 51 blue day 56 2
De Hullu (2000) 59 blue day + radiocolloid 100 0
Sideri (2000) 44 radiocolloid 100 0
De Cicco (2000) 37 radiocolloid 100 0
Levenback (2001) 52 blue day 88 3
Sliutz (2002) 26 blue day + radiocolloid 100 0
Puig-Tintore (2003) 26 blue day + radiocolloid 96 0
Moore (2003) 21 blue day + radiocolloid 100 0
Merisio (2005) 10 radiocolloid 100 3
Terada (2006) 21 blue day + radiocolloid 100 0
Haupsy (2007) 41 blue day + radiocolloid 95 0
Sentinel lymph node detection rates in vulvar cancer
19. mul$center
study
Hampl
et
al.
in
2008.
127 pa5ents
with
stage
T1
–
T3
squamous
cell
cancer
lesions.
128 With
early
stage
vulva
cancer
with
use
of
SLNS
detec$on
rate
false-‐nega$ve
rate
sensi$vity
125
of
the
127
pa$ents
98%
7.7%
92.3%
21. Criteria
for
SLNS
IN
VULVA
CANCER
EXPERT
PANEL!
• Tumors
4
cm
or
less,
• Clinically
nega$ve
groins,
and
tumor
invasion
greater
than
1mm
• midline
tumors
should
have
bilateral
SLN
biopsies
performed.
• Competency
:
An
expert
panel
recommended
an
arbitrary
number
of
10
consecu$ve
cases
with
successful
SLN
iden$fica$on
and
no
false-‐
nega$ve
results
be
performed
prior
to
performing
SLN
biopsy
without
lymphadenectomy
22. Vulvar
SLNS
protocol
-‐ve
+ve
Complete
lymphadenectomy
Groin
radia$on
No
further
disec$on
sixth
biennial
meet-‐
ing
of
the
Interna$onal
Sen$nel
Lymph
Node
Society
an
expert
panel
issued
a
statement
2008
23. GROINSS-‐V-‐I(mul$center
observa$onal
study)
radioac$ve
tracer
and
blue
dye,
in
pa$ents
with
unifocal
vulvar
squamous
cell
carcinoma
less
than
4cm
in
diameter.
-‐ve
276
+ve
No
pts
403
Follow
up
lymphadenectomy
Recurrent
8
(2.9%)
lymphodema
1.9%
25.2%
(p<0.001)
24. P
value
SLNS
lymphadenectomy
p<0.001
0.4%
16.2%
Recurence
erysipelas
p<0.001
4.5%
21.3%,
Celluli$ts
p<0.001
11.7%
34%
Wound
breakdown
p<0.001
8.4
days
13.7
days
Hospital
stay
97%
Disease-‐specific
survival
rate
for
pa$ents
with
unifocal
vulvar
cancer
and
nega$ve
SLN
27. • in
summary,
SLN
biopsy
in
early-‐stage
vulvar
cancer
pa$ents
appears
to
be
a
reasonable
alterna$ve
to
complete
inguinal
lymphadenectomy.
28. Cervical
cancer
• Standard
treatment
for
early
stage
radical
hystrectomy
/trachlectomy
and
pelvic
lymphadnectomy
• Complica$on
include
short
term
morbidity
and
long
term
• Lymphcyst
and
lymphoedema
and
nerve
and
vascular
injury
29. • Cervix
:-‐
– Two
groups
:
• Primary
groups:
Paracervical,
parametrial,
obturator,
internal
and
external
iliac
nodes.
• Secondary
groups:
Common
iliac,
para-‐
aor$c,
and
lateral
sacral
lymph
nodes.
34. Cervical
Sen$nel
LN
mapping
• the
cervical
stroma
is
injected
circumferen$ally.
Peri-‐
tumoral
injec$on
is
preferred,
as
it
should
allow
the
tracer
to
follow
the
same
path
as
the
lympha$c
drainage
of
the
lesion
itself.
Near-‐infrared
fluorescence
imaging
using
indocyanine
green
35. Authors No. of Patients Detection method
Unilateral Detection
percentage
Bilateral detection
percentage
Faise-negative
percentage
O’Boyle (2000) 20 blue day 70 42 0
Malur (2001) 50 blue day 55 NS 17
radiocolloid 76 NS
blue day + radiocolloid 90 NS
Levenback (2002) 39 blue day + radiocolloid 100 NS 13
Dargent (2003) 70 blue day + radiocolloid 90 NS 0
Plante (2003) 70 blue day + radiocolloid 93 72 0
blue day 83 51
Hubalewska (2003) 37 blue day + radiocolloid 100 65
Pijpers (2004) 37 blue day + radiocolloid 97 94 8
Rob (2005) 183 blue day + radiocolloid 96 90 3
blue day 80 62
Di Stefano (2005) 50 blue day 90 60 10
Silva (2005) 56 radiocolloid 93 38 18
Angioli (2005) 37 radiocolloid 70 31 0
Wydra (2006) 100 blue day + radiocolloid 100 66 3
Frumovitz (2006) 50 blue day + radiocolloid 96 60 0
Kraft (2006) 54 blue day + radiocolloid 93 43 0
Haupsey (2007) 42 blue day + radiocolloid 98 72 0
Yuan (2007) 81 blue day 83 78 23
Seong (2007) 89 blue day 57 NS 9
Fader (2008) 38 blue day + radiocolloid 92 47 3
Altgassen (2008) 590 blue day + radiocolloid 89 NS 4
Sentinel lymph node detection rates in cervical cancer
36. • GOG
206,
an
ongoing,
mul$center
trial
examining
the
u$lity
of
SLN
biopsy
in
early
cervical
cancer
pa$ents.
• Pending
result……..
• These
results
will
likely
direct
future
research
on
this
topic.
38. Endometrial
cancer
• Standard
management
hysterectomy
and
bso
and
pelvic
and
para
aor$c
lymphadnectomy
• Lymphadnectomy
associated
with
increase
morbidity
and
mortality
• Most
onen
all
node
be
nega$ve
especially
in
early
stage
and
grade
1
39. • Uterus
:-‐
– Pelvic
Lymph
node
– para-‐aor$c
LNs
via
the
ovarian
vessels
40. • 90%
of
pa$ents
with
stage
I
endometrium
cancer
will
not
have
lymph
node
metastasis
at
the
$me
of
diagnosis
41. Problem
with
standard
lymphadnectomy
• Short
and
long
term
morbidity
• Chance
of
missing
posi$ve
Lymph
node
45. Authors
No. of
Patients
Injection site Detection method
Unilateral Detection
percentage
Bilateral detection
percentage
Faise-negative
percentage
Burke (1996) 15 SSM blue day 67 NS 50
Echt (1999) 8 SSM blue day 0 0 0
Holub (2002) 13 SSM blue day 62 NS 0
12 SSM + PC blue day 83 NS 0
Pelosi (2002) 16 PC blue day + radiocolloid 94 56 0
Gargiulo (2003) 11 PC blue day + radiocolloid 100 35 0
Raspagliesi (2004) 18 HS blue day + radiocolloid 100 NS 0
Holub (2004) 25 SSM + PC blue day 84 81 0
Fersis (2004) 10 HS radiocolloid 70 20 0
Niikura (2004) 28 HS radiocolloid 82 NS 0
Maccuro (2005) 26 HS blue day + radiocolloid 100 NS 0
Bats (2005) 26 PC blue day + radiocolloid 81 NS 0
Li (2007) 20 SSM blue day 75 NS Ns
Frumovitz (2007) 18 SSM blue day + radiocolloid 45 39 0
Altgassen (2007) 23 SSM blue day 92 NS NS
Delpech (2007) 23 PC blue day + radiocolloid 83 48 NS
Barranger (2009) 33 PC blue day + radiocolloid 82 54 0
Sentinel lymph node detection rates in endometrial cancer
46. • A
meta-‐analysis
of
26
studies
including
1101
sen$nel
node
procedures
found
a
sensi$vity
of
93
percent
for
the
detec$on
of
lymph
node
metastases
in
women
with
endometrial
carcinoma
.
• Studies
have
evaluated
two
sites
of
injec$on
for
SLN
mapping:-‐
• percervical
.
(Higher
detec$on
rate)
•
hysteroscopically-‐guided
(Lower
detec$on
rate).
49. Conclusion
• Sen$nel
node
mapping
will
allow
for
selec$ve
removal
of
nodes
at
risk,
while
sparing
other
nodes
and
reducing
opera$ve
morbidity
substan$ally.
• For
gynecologic
cancers,
the
results
are
promising,
par$cularly
for
vulvar
cancer
which
can
be
an
alterna$ve
of
the
standard
of
care
• This
technological
advancement
will
be
considered
promising,
but
not
yet
a
standard
of
care
for
treatment
of
women
with
endometrium
and
cervical
cancer
50. Conclusion
• The
safety
of
the
SLN
procedure
is
strongly
associated
with
the
number
of
women
treated
within
a
specific
center
and
the
presence
of
a
well
trained
oncology
team
• Given
the
collec$ve
interest
in
the
less
morbid
treatment
for
pa$ents
with
gynecological
cancer,
sen$nel
node
mapping
deserves
con$nued
development.